178 related articles for article (PubMed ID: 36233180)
21. The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.
Mackenzie IR; Rademakers R
Curr Opin Neurol; 2008 Dec; 21(6):693-700. PubMed ID: 18989115
[TBL] [Abstract][Full Text] [Related]
22. RNA and Protein Interactors with TDP-43 in Human Spinal-Cord Lysates in Amyotrophic Lateral Sclerosis.
Volkening K; Keller BA; Leystra-Lantz C; Strong MJ
J Proteome Res; 2018 Apr; 17(4):1712-1729. PubMed ID: 29513014
[TBL] [Abstract][Full Text] [Related]
23. TARDBP (TDP-43) sequence analysis in patients with familial and sporadic ALS: identification of two novel mutations.
Del Bo R; Ghezzi S; Corti S; Pandolfo M; Ranieri M; Santoro D; Ghione I; Prelle A; Orsetti V; Mancuso M; Sorarù G; Briani C; Angelini C; Siciliano G; Bresolin N; Comi GP
Eur J Neurol; 2009 Jun; 16(6):727-32. PubMed ID: 19236453
[TBL] [Abstract][Full Text] [Related]
24. "STRESSED OUT": The role of FUS and TDP-43 in amyotrophic lateral sclerosis.
Aksoy YA; Deng W; Stoddart J; Chung R; Guillemin G; Cole NJ; Neely GG; Hesselson D
Int J Biochem Cell Biol; 2020 Sep; 126():105821. PubMed ID: 32758633
[TBL] [Abstract][Full Text] [Related]
25. TDP-43 Puts the STING in ALS.
Lee JD; Woodruff TM
Trends Neurosci; 2021 Feb; 44(2):81-82. PubMed ID: 33353765
[TBL] [Abstract][Full Text] [Related]
26. Mitochondria, ER, and nuclear membrane defects reveal early mechanisms for upper motor neuron vulnerability with respect to TDP-43 pathology.
Gautam M; Jara JH; Kocak N; Rylaarsdam LE; Kim KD; Bigio EH; Hande Özdinler P
Acta Neuropathol; 2019 Jan; 137(1):47-69. PubMed ID: 30450515
[TBL] [Abstract][Full Text] [Related]
27. High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis.
Corrado L; Ratti A; Gellera C; Buratti E; Castellotti B; Carlomagno Y; Ticozzi N; Mazzini L; Testa L; Taroni F; Baralle FE; Silani V; D'Alfonso S
Hum Mutat; 2009 Apr; 30(4):688-94. PubMed ID: 19224587
[TBL] [Abstract][Full Text] [Related]
28. Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD.
Wood A; Gurfinkel Y; Polain N; Lamont W; Lyn Rea S
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946763
[TBL] [Abstract][Full Text] [Related]
29. Oxr1 improves pathogenic cellular features of ALS-associated FUS and TDP-43 mutations.
Finelli MJ; Liu KX; Wu Y; Oliver PL; Davies KE
Hum Mol Genet; 2015 Jun; 24(12):3529-44. PubMed ID: 25792726
[TBL] [Abstract][Full Text] [Related]
30. Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72.
Cooper-Knock J; Hewitt C; Highley JR; Brockington A; Milano A; Man S; Martindale J; Hartley J; Walsh T; Gelsthorpe C; Baxter L; Forster G; Fox M; Bury J; Mok K; McDermott CJ; Traynor BJ; Kirby J; Wharton SB; Ince PG; Hardy J; Shaw PJ
Brain; 2012 Mar; 135(Pt 3):751-64. PubMed ID: 22366792
[TBL] [Abstract][Full Text] [Related]
31. Pathological and immunoblot analysis of phosphorylated TDP-43 in sporadic amyotrophic lateral sclerosis with pallido-nigro-luysian degeneration.
Uchino A; Ogino M; Takahashi-Fujigasaki J; Oonuma S; Kanazawa N; Kajita S; Ichinoe M; Hasegawa M; Nishiyama K; Murayama S
Neuropathology; 2018 Apr; 38(2):171-178. PubMed ID: 28906030
[TBL] [Abstract][Full Text] [Related]
32. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis.
Van Deerlin VM; Leverenz JB; Bekris LM; Bird TD; Yuan W; Elman LB; Clay D; Wood EM; Chen-Plotkin AS; Martinez-Lage M; Steinbart E; McCluskey L; Grossman M; Neumann M; Wu IL; Yang WS; Kalb R; Galasko DR; Montine TJ; Trojanowski JQ; Lee VM; Schellenberg GD; Yu CE
Lancet Neurol; 2008 May; 7(5):409-16. PubMed ID: 18396105
[TBL] [Abstract][Full Text] [Related]
33. Modeling hallmark pathology using motor neurons derived from the family and sporadic amyotrophic lateral sclerosis patient-specific iPS cells.
Sun X; Song J; Huang H; Chen H; Qian K
Stem Cell Res Ther; 2018 Nov; 9(1):315. PubMed ID: 30442180
[TBL] [Abstract][Full Text] [Related]
34. Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p.
Hsiung GY; DeJesus-Hernandez M; Feldman HH; Sengdy P; Bouchard-Kerr P; Dwosh E; Butler R; Leung B; Fok A; Rutherford NJ; Baker M; Rademakers R; Mackenzie IR
Brain; 2012 Mar; 135(Pt 3):709-22. PubMed ID: 22344582
[TBL] [Abstract][Full Text] [Related]
35. Oligogenic inheritance of optineurin (OPTN) and C9ORF72 mutations in ALS highlights localisation of OPTN in the TDP-43-negative inclusions of C9ORF72-ALS.
Bury JJ; Highley JR; Cooper-Knock J; Goodall EF; Higginbottom A; McDermott CJ; Ince PG; Shaw PJ; Kirby J
Neuropathology; 2016 Apr; 36(2):125-34. PubMed ID: 26303227
[TBL] [Abstract][Full Text] [Related]
36. Alterations in subcellular localization of TDP-43 immunoreactivity in the anterior horns in sporadic amyotrophic lateral sclerosis.
Sasaki S; Takeda T; Shibata N; Kobayashi M
Neurosci Lett; 2010 Jul; 478(2):72-6. PubMed ID: 20447446
[TBL] [Abstract][Full Text] [Related]
37. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ
Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983
[TBL] [Abstract][Full Text] [Related]
38. Reduced mitochondrial D-loop methylation levels in sporadic amyotrophic lateral sclerosis.
Stoccoro A; Smith AR; Mosca L; Marocchi A; Gerardi F; Lunetta C; Cereda C; Gagliardi S; Lunnon K; Migliore L; Coppedè F
Clin Epigenetics; 2020 Sep; 12(1):137. PubMed ID: 32917270
[TBL] [Abstract][Full Text] [Related]
39. Mitochondrial defect in muscle precedes neuromuscular junction degeneration and motor neuron death in CHCHD10
Genin EC; Madji Hounoum B; Bannwarth S; Fragaki K; Lacas-Gervais S; Mauri-Crouzet A; Lespinasse F; Neveu J; Ropert B; Augé G; Cochaud C; Lefebvre-Omar C; Bigou S; Chiot A; Mochel F; Boillée S; Lobsiger CS; Bohl D; Ricci JE; Paquis-Flucklinger V
Acta Neuropathol; 2019 Jul; 138(1):123-145. PubMed ID: 30874923
[TBL] [Abstract][Full Text] [Related]
40. Maintaining the balance of TDP-43, mitochondria, and autophagy: a promising therapeutic strategy for neurodegenerative diseases.
Huang C; Yan S; Zhang Z
Transl Neurodegener; 2020 Oct; 9(1):40. PubMed ID: 33126923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
